700 patients110,866 observations180 daysLIVE

Patient P-02167

Synthetic patientMETA-24 · Day 180 · 65–74 · M · baseline S02Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Favorable
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Improving
Discontinuation risk
7%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 startedBaseline state S02
  2. Day 15 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 22 HY-01 recommendedHydration Protocol HY-01
  4. Day 23 Patient acceptedStarted HY-01 in the companion
  5. Day 27 GI symptom burden −15% vs expectedHydration Protocol HY-01
  6. Day 33 Tolerance state changedUnstable → Improving

What changed?

Trajectory began diverging from predicted response on Day 15.

Primary contributors, last 14 days
  • GI instability-15
  • Inflammatory activity-11
  • Nutritional resilience+7
  • Treatment adherence+3

What helped?

  • Hydration Protocol HY-01Day 22
    Result: symptom burden −15%
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes
Wearable
32 min
worsening · -2.4 vs previous 14 d
Sleep duration
Wearable
7.6 h
stable · +0.2 vs previous 14 d
Energy level
Daily log
6.9/10
improving · +0.6 vs previous 14 d
Steps
Wearable
3,990
improving · +140 vs previous 14 d
GI burden
Companion
12.8/100
improving · -9.5 vs previous 14 d
Adherence
Companion
91.7 %
stable · +0.1 vs previous 14 d
Sleep quality
Wearable
66.5/100
improving · +3.8 vs previous 14 d
Glucose, CGM daily mean
CGM
121 mg/dL
improving · -7.9 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →

Heading towards restoration · 82 from the failing basin, 25 from restoration.

Good elements to keep
  • Protein (supports)
    perturbation · steering +10.6
  • Hydration Protocol HY-01
    intervention · steering +9.7
  • Daily walks resumed
    perturbation · steering +3.3
  • Protein
    supporter · GI -5.5 next day
Main detractors to watch
  • Low butyrate capacity
    hidden · steering -17.5
  • Ultra-processed food
    perturbation · steering -8.5
  • Low microbial diversity
    hidden · steering -7.7
  • Bacteroides fragilis elevated
    hidden · steering -7.4
  • Ultra-processed food
    detractor · GI +5.4 next day
  • Simple carbohydrates
    detractor · GI +4.9 next day
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Protein
    -5.5supporter · 95%
  • Ultra-processed food
    +5.4detractor · 95%
  • Simple carbohydrates
    +4.9detractor · 95%
  • Dietary fat load
    +4.4detractor · 95%
  • Insoluble fibre
    -1.4no signal · 29%
  • Caffeine
    -0.8no signal · 15%
  • Alcohol
    -0.7no signal · 15%
  • Histamine load
    +0.4no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Butyrate / short-chain fatty acid production 35
    • MicrobiomeButyrate capacity 26/100
  • Mucosal barrier integrity 30
    • MicrobiomeAkkermansia low → thinner mucus layer
  • Inflammatory signalling 20
    • MicrobiomeBacteroides fragilis expansion
  • Autonomic recovery 20
    • Wearable3,990 steps/day
DNA
Fictional pharmacogenomic panel
  • CYP2D6 Normal metabolizer
    Expected exposure
Microbiome
Shannon diversity 2.4 · butyrate capacity 26/100
  • Akkermansia muciniphilaLow
  • Faecalibacterium prausnitziiNormal
  • Bacteroides fragilisHigh
  • Bifidobacterium longumLow
  • EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
HRV
59 ms
Sleep
7.6 h
Steps
3,370
Resting HR
70 bpm
Daily log: GI score 13, nutritional resilience 67, adherence 92.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Keep meals regular; three to four moderate portions spaced through the day
  • Include a cooked vegetable portion with each main meal
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
  • Log the daily check-in; one line is enough
  • A 15-minute walk after lunch
  • Keep the sleep window steady
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the dose at the same time relative to your evening meal
  • No additional supplements this week
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0268143%S0151
P-0221842%S01DT-01improved61
P-0262042%S01HY-01improved64
P-0221740%S0161
P-0242438%S0162
P-0256837%S0151
P-0263836%S01BR-03improved41
P-0208735%S01BR-03no change40
P-0243735%S0164
P-0227634%S0157
P-0230733%S0155
P-0252232%S01BR-03no change40